Itaconate is a covalent inhibitor of the Mycobacterium tuberculosis isocitrate lyase?

RSC Medicinal Chemistry Pub Date: 2020-10-19 DOI: 10.1039/D0MD00301H

Abstract

Itaconate is a mammalian antimicrobial metabolite that inhibits the isocitrate lyases (ICLs) of Mycobacterium tuberculosis. Herein, we report that ICLs form a covalent adduct with itaconate through their catalytic cysteine residue. These results reveal atomic details of itaconate inhibition and provide insights into the catalytic mechanism of ICLs.

Graphical abstract: Itaconate is a covalent inhibitor of the Mycobacterium tuberculosis isocitrate lyase
Recommended Literature